John Osborne

Orchid

Papers

1

Total Citations

14

H-Index

1

About

Dr. John Osborne is a leading urologic oncologist whose research focuses on the surgical management of genitourinary malignancies, with a particular emphasis on penile carcinoma. His most impactful contribution is a landmark 2023 systematic review and meta-analysis that rigorously evaluated minimally invasive procedures for surgical inguinal nodal staging in penile cancer. This work, which has garnered 14 citations in a short time, provides crucial evidence for reducing morbidity in staging while maintaining oncologic accuracy. Dr. Osborne’s research addresses a critical gap in penile cancer care, where traditional open inguinal lymphadenectomy carries significant complications. By synthesizing data on laparoscopic and robotic-assisted techniques, he has helped establish best practices that improve patient recovery and quality of life. His work is widely cited by clinicians and researchers seeking to refine surgical approaches for this rare but aggressive disease. Dr. Osborne continues to advance the field through ongoing clinical trials and collaborations, solidifying his reputation as a key voice in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile Carcinoma
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Orchid

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago